LYRA — Lyra Therapeutics, Inc.

LYRALyra Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · lyratherapeutics.com

0.7000USD-6.67%Mkt Cap: 1.24M USDP/E: —Last update: 2026-05-26

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology i…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.24M USD

Enterprise Value15.61M USD

Revenue (TTM)398.00K USD

Gross Profit-608.00K USD

Net Income (TTM)-28.92M USD

Revenue/Share0.2560 USD

Last Price0.7000 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees27

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.71

PEG—

EV/EBITDA-0.54

EV/Revenue39.22

P/S3.12

P/B-0.12

EPS (TTM)-18.62

EPS (Forward)-0.99

52W Range

0.31001% of range37.50

52W High37.50 USD

52W Low0.3100 USD

Profitability

Gross Margin-152.76%

Oper. Margin-98728.57%

EBITDA Margin0.00%

Profit Margin-7266.08%

ROE269.84%

ROA-80.09%

Growth

Revenue Growth-96.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF-28.86M USD

CapEx (TTM)116.00K USD

FCF Margin-4404.43%

FCF Yield-1410.93%

Net Debt14.37M USD

Net Debt/EBITDA-0.49

Balance Sheet

Debt/Equity-2.82

Current Ratio1.71

Quick Ratio1.67

Book Value/Sh-6.0380 USD

Cash/Share8.954 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:50

Split DateMay 28, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.77M

Float466.79K

Insiders0.62%

Institutions13.26%

Short Interest

Short Ratio0.3d

Short % Float1.10%

Short % Out.0.93%

Shares Short16.53K

Short (prev mo.)59.09K

Technical

SMA 500.6438 (+8.7%)

SMA 2003.385 (-79.3%)

Beta0.69

S&P 52W Chg28.31%

Avg Vol (30d)9.76K

Avg Vol (10d)9.21K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—